SuPAR and Chronic Kidney Disease: Identifying Biomarkers for Disease Progression
Download Transcript, Episode 71 (64 KB)
Darcy K. Weidemann, MD
Length of Episode
SuPAR (soluble urokinase-type plasminogen activator receptor) has been shown to be a promising biomarker in its ability to predict the development of chronic kidney disease in adults years earlier than traditional risk factors.
Darcy Weidemann, MD, pediatric nephrologist at Children’s Mercy is leading the largest North American study ever conducted to look at whether suPAR may be helpful to predict kidney function decline in children.
Listen in to Darcy Weidemann, MD as she explains the potential role that monitoring suPAR levels may play in improving the care of children with chronic kidney disease.
Smith, Michael and Weidemann, Darcy, "SuPAR and Chronic Kidney Disease: Identifying Biomarkers for Disease Progression" (2016). Transformational Pediatrics Podcast. 71.